Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)

INTRODUCTION: Glucocorticoids are still a mainstream of rheumatoid arthritis (RA) treatment. Reducing glucocorticoids should be attempted in all patients. However, choosing the right tapering strategy is challenging. The primary aim of our study is to determine the dose–response association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Adami, Giovanni, Fassio, Angelo, Rossini, Maurizio, Bertelle, Davide, Pistillo, Francesca, Benini, Camilla, Viapiana, Ombretta, Gatti, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815081/
https://www.ncbi.nlm.nih.gov/pubmed/36599630
http://dx.doi.org/10.1136/rmdopen-2022-002792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815081/
https://www.ncbi.nlm.nih.gov/pubmed/36599630
http://dx.doi.org/10.1136/rmdopen-2022-002792

Ejemplares similares